09/03/2026
Researchers are studying new ways to treat wet and dry age-related macular degeneration, including approaches that could reduce how often patients need injections. Read the article to learn more about how these emerging therapies could shape the future of AMD care: https://brnw.ch/21x5pDf
Gene therapies, Tie2 agonism, and new delivery platforms are advancing through phase 3 trials in wet and dry AMD, testing mechanisms distinct from anti-VEGF and complement inhibition.